Anthony Vecchione
The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.
Researchers at Johns Hopkins found that the AI outperformed current clinical guidelines with 89% accuracy across all patients and a 93% accuracy rate for individuals ages 40 to 60.
The company will use the funds to develop its employee assistance program platform, expand global clinical access and increase partnerships.
The UroNav system uses MRI and ultrasound images for more precise, minimally invasive care.
Pregnant and postpartum patients will have access to an app and educational programs to help them develop skills to manage the challenges of pregnancy and parenthood.
Anervea.ai will develop and deploy an AI-powered suite of applications on Komodo's MapLab Enterprise platform.
The oncology-focused company will use the funds to boost manufacturing capacity, grow its commercial team and develop its next-generation Amma product.
The funds will be used to expand the company's enterprise-grade platform, aiOS, and accelerate the development of CARE, a clinical-grade foundation model.
The company aims to simplify the Medicaid enrollment and recertification process and will use the funds to expand into new states and scale its infrastructure.
The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.